Events
No upcoming events at the moment.
You are about to leave the Clinical Value website now.
Cancel
Continue
Past Virtual Events
IPVC 2023 – How Peru broke down barriers to cervical cancer screening
IPVC 2023 – Optimising screening and triage for cervical cancer: Prof Mark Stoler on why biomarkers are best
AOGIN 2022 – Advancing women’s health: optimising cervical cancer screening in Thailand
AOGIN 2022 – Advancing women’s health: HPV screening methods in Singapore
APASL 2024 Kyoto Seminar
Watch the APASL 2024 seminar recording to hear experts share key updates on curative approaches to HCC management, treatment apporaches for BCLC-B uHCC, and real world…
READ MORE
ESMO 2023 Symposium – Redefining Lung Cancer Together: A New Era For Patients
Missed the satellite symposium session from ESMO 2023? Access the webcast recording here.
READ MORE
ESMO Asia 2023 Symposium – HCC illuminated: Exploring future frontiers with systemic immunotherapies
Missed the satellite symposium session from ESMO Asia 2023? Access the webcast recording here.
READ MORE
Guiding the way: The role and value of algorithms in liver disease care journey
PIVKA-II in action: Clinical case studies on HCC surveillance and management
Panel discussion: Charting directions: Integrating new algorithms and approaches in practice
Navigating the Health Economic Data in APAC: Present challenges and future directions
HCC Surveillance in China: A Journey Towards Improving Patient Care and Outcomes
Real World Data Unveiled: Results and insights of GAAD in surveillance population
The Practice in Japan: Insights into gold standard HCC surveillance and management
APAC Oncology Summit 2023 Webinar
The right tools at the right time: Liquid Biopsy enters the clinic
The field of clinical oncology continues to see drastic advancements with non-invasive techniques, such as liquid biopsy being adopted for diagnosing and monitoring cancers in place…
READ MORE
No time to wait: Evolving testing & treatment landscape in early stage lung cancer
Lung cancer has seen tremendous advancements over the past decade with the emergence of targeted therapies directed against mutant onco-proteins and immune checkpoint inhibitors. Join the…
READ MORE
ESMO 2022 Symposium – Redefining Lung Cancer Together: Now and Next
Missed the satellite symposium session from ESMO 2022? Access the webcast recording here.
READ MORE
Value-based care in lung cancer: a case study from Belgium
To enable value-based healthcare, several important steps are needed. In this presentation and Q&A, Ingel Demedts discusses the project “Value-based care in lung cancer: a case…
READ MORE
Digital Tools to Drive NGS Clinical Application for the Future
The growing amount of clinical data available for each patient, clinicians need to manage massive genomic information, histological analysis tools, and clinical trials and publications. They…
READ MORE
Connecting Oncology and Pathology in the personalized care of NSCLC patients
Treatment landscape of NSCLC has been evolving dramatically in the past ten years, and biomarker testing is becoming increasingly complex. Join the webinar to hear from…
READ MORE
Clinical Utility of Liquid Biopsy in EGFR testing for Lung Cancer
Several EGFR tyrosine kinase inhibitors are recommended by international guidelines as first-line treatment for patients with EGFR mutations. While tissue biopsy samples continue to be the…
READ MORE
The importance of EGFR CDx testing and recent treatment updates in early stage NSCLC
Several EGFR Tyrosine Kinase Inhibitors are recommended by international guidelines as first-line treatment for patients with EGFR mutations. A robust and approved Companion Diagnostic (CDx) assay…
READ MORE
Lung Cancer Diagnostics Post COVID – a Multidisciplinary View
Various diagnostic tools play indispensable roles in diagnosing, staging, treatment selection & monitoring of lung cancer patients. Join the webinar to hear from pulmonologist Dr James…
READ MORE
APASL 2023 Taiwan Symposium
Watch the APASL 2023 symposium recording to hear experts share key updates on HCC surveillance, diagnosis, uHCC management and adj HCC systemic treatment.
READ MORE
Value of PIVKA-II in surveillance and treatment monitoring for patients with advanced HCC
This presentation has 2 parts. In the first part of this presentation, Prof. Nobuharu Tamaki discusses the diagnostic utility of PIVKA-II in HCC, and the potential…
READ MORE
HCC Patient Journey and biomarkers’ roles in the HCC management
Detection of HCC at early stages remains a challenge, with less than 20% of patients being diagnosed at an early stage, when they can benefit from…
READ MORE
The clinical utility of HCC algorithms as aids in the diagnosis of HCC
In this presentation, Prof. Ming Lung Yu discusses the results of his study, which aims to address the diagnostic accuracy of HCC using Elecsys GAAD algorithmic…
READ MORE
Review of PIVKA-II expert consensus from APASL presentation
In this presentation, Prof. Do Young Kim reviews the results of the APAC expert consensus study on the utilization of PIVKA-II in the surveillance and monitoring…
READ MORE
APASL 2022 Seoul
The liver cancer landscape has been undergoing a period of rapid transformation. From early detection of HCC using new biomarkers, to new immunotherapy treatment options. Watch…
READ MORE
Global HCC Expert Series
Join our experts for a series of on-demand webinars, focused on clinical insights and knowledge from the fields of oncology, hepatology, interventional radiology, and surgery, to…
READ MORE
APPLE 2021 – Biomarker In HCC Surveillance And Treatment: The New Evidence On The Horizon
Join the webinar to hear speakers Prof. Henry Chan and Prof. Hui Chuan Sun as they discuss the use of PIVKA-II and GAAD score as promising…
READ MORE
APASL 2021 – The First Line Treatment in Unresectable HCC: From Evidence To Practice
Join the webinar to hear speakers Prof. Henry Chan, and Assoc. Prof. Teerha Piratvisuth as they discuss the clinical usefulness of PIVKA-II in HCC surveillance, as…
READ MORE